B7-transfectant tubular epithelial cells induce T cell anergy, ignorance or proliferation. We have previously established that interferon (IFN)-y stimulated, antigen-pulsed tubular epithelial cells (TEC) stimulate antigen (Ag) specific activation of T cell hybridomas to express IL-2, In contrast, these Ag pulsed TEC do not stimulate T helper I (Thi) clones to proliferate, but rather render them unresponsive, since Ag pulsed spleen cells cannot restore these cells to proliferate. The interaction of the T cell CD28 surface protein with its ligand B7 expressed on Ag presenting cells bearing Ia is a potent co-stimulatory signal capable of inducing T cell proliferation. Hence, the lack of 87 on TEC was hypothesized to be responsible for anergy in these ThI cells. Therefore, the B7 gene was transfected into a SV4O transformed TEC or Chinese hamster ovary (CHO) cells, and created TEC and CHO cells expressing surface B7 protein. TEC-B7 (IFN-y stimulated, Ag pulsed) express Ia and induce IL.2 production by T cell hybridomas. In contrast, T cell proliferation was not induced by TEC-B7 or CHO-B7 cells; however, these Thi cells were not anergic since they could be stimulated to proliferate to Ag pulsed spleen cells (immunological ignorance). However, co-cultivating TEC-B7 (IFN-y stimulated, Ag pulsed) with Thi cells stimulated through the T cell receptor (TCR) using anti-CD3 monoclonal antibody (mAb) caused these Thl cells to proliferate. Furthermore, anti-CD28 and anti-B7 mAbs blocked this response. These data suggest that the spectrum of ThI cell activation after encounter with Ag is dictated by: (I) the vigor of TCRJCD3 signal, and (2) presence or absence of co-stimulatory signals through the CD28 pathway. Since expression of Ia on TEC induces anergy, this may serve as a mechanism to thwart-not foster-autoimmunity.
to provide the costimulatory signal required to facilitate Agstimulated T cell activation [14] [15] [16] [17] [18] [19] [20] . Monovalent anti-CD28 IgG/Fab mAb, anti-B7 mAb or a fusion protein consisting of the extracellular domain of human CTLA-4 genetically linked to human constant region IgGyl heavy chains (CTLA4Ig) inhibit the human allogeneic mixed leukocyte culture (MLC) and T cell dependent antibody production in both human and mouse models [13, . Indeed, human MLC treated with CTLA4Ig induces a state of Ag specific T cell hyporesponsiveness, that is, anergy [24] . Clearly, the CD28/CTLA4 pathway is a major costimulatory pathway for T cell activation.
Many investigators have noted the unusual expression of Ia upon parenchymal epithelial cells, such as the thymus, small intestine and target cells of various non-lymphoid tissues in autoimmune diseases, and have speculated that increased Ia expression may play an important role in the pathogenesis of autoimmune tissue injury [25] [26] [27] [28] [29] [30] . Over a decade ago Botazzo proposed that Ia expression on target cells of autoimmune diseases such as thyroid epithelial cells would result in presentation of self-Ags to T cells and thereby promote or facilitate autoimmune tissue injury [30] . However, some recent studies have suggested that Ag presented by parenchymal Ia cells ("non-professional APCs") might induce mature peripheral T cell clonal anergy/tolerance as a result of the inability of these cells to deliver costimulatory signals required for T cell activation [25, 26] . For example, renal tubular epithelial cells (TEC) can express Ia during allograft rejection, autoimmune renal injury and graft versus host disease [27-29, 31, 32] . We have determined that: (i) TEC clones can be induced to express both I-A and I-E MHC-class II molecules following IFN-y stimulation in vitro, and (ii) Ag-pulsed, Ia TEC stimulate Ag-specific T cell hybridomas to secrete IL-2 [33] . Since T cell hybridomas are more readily activated by Ag alone than normal T cells, we designed studies to determine whether Ag pulsed, Ia TEC could activate normal T cell clones. In contrast to the results noted with Ag-specific T cell hybridoinas, Ag pulsed, Ia TEC not only fail to activate IL-2 producing T cells, but renders cloned IL-2 producing T cells anergic [34] . In addition, transgenic mice that express high levels of MHC-class II molecules on TEC do not initiate autoimmune injury in a transplant model [35] . Hence, we hypothesized that the failure of Ag pulsed Ia TEC to deliver effective costimulatory signals was a result of the inability to express a costimulatory molecule such as the B7 ligand.
This report examines the ability of TECs transfected with murine B7 encoding cDNA to provide costimulatory molecules to mouse Thi clones in order to test this hypothesis. For this purpose, we established mouse B7 TEC lines (TEC-B7), and analyzed Ag pulsed, IFN-y stimulated (Ia)TECs for their capacity to stimulate Thi clones to proliferate. Ag-pulsed, IFN-'y stimulated TECs, but not TEC-B7, rendered cloned IL-2 producing T cells anergic. Hence, the presence or absence of expression of B7 can determine whether TEC can induce anergy. While Ag-pulsed, IFN-y stimulated TEC-B7 do not stimulate the proliferation of cloned IL-2 producing T cells, if the TCRs of IL-2 producing T cells are stimulated with both Ag and anti-CD3 mAb these Thi clones proliferate. Hence, the capacity of Ag pulsed, Ia epithelial cells expressing B7 to stimulate T cell proliferation depends at least in part upon the ability of epithetial cells to provide an intense signal through the TCRICD3 complex. Clearly, the role of Ia parenchymal cells in causing autoimmunity must be re-evaluated.
Methods
Mice C3H/FeJ (H2k) female mice were purchased from The Jackson Laboratory (Bar Harbor, Maine, USA) and maintained in our animal facility. Mice were used between 6 to 12 weeks of age.
Cell clones
A.E7, a pigeon cytochrome c (amino acids 81-104)-specific, IEkrestricted Thl cell clone, was provided by Dr. Abul Abbas (Brigham and Women's Hospital, Boston, Massachusetts, USA) [36, 37] . A2.A2, a subclone of the T cell hybridoma A2.2B2 which recognizes hen egg lysozyme in the context of!-A' [38] , was provided by Dr. Laurie Glimcher (Harvard School of Public Health, Boston, Massachusetts, USA), respectively. HT-2 cells, an IL-2/!L-4-dependent cell line were provided by Dr. Abul Abbas. CS3.1 is a renal TEC clone derived from C3H/FeJ mice. The method of isolation has been previously described [33, 34] . Briefly, TEC were prepared by collagenase dispersion and sequential sieving of renal cortices. Cells were subcloned by the limiting dilution technique after transformation with origin-defective SV4O DNA. These TEC have morphologic and physiologic characteristics of proximal TEC and can be stimulated by IFN-y to express Ia and enhance the level of intercellular adhesion molecule-l (ICAM-l) on its surface. B? transfected CS3.1 (TEC-B7) and Chinese hamster ovary (CHO) (CHO-B7) cells Murine B7 cDNA was subcloned into the pRC/CMV expression vector [12] . TEC and CHO cells were transfected with 20 g pRC/CMV/B7 plasmid by electroporation (1.5 KY, 30 pFD) using a Gene Pulser (Bio-Rad Laboratories, Richmond, California, USA) and selected in culture medium (Ki medium, 1:1 mixture of Dulbecco's modified Eagle's medium (DMEM) and Ham's F12, containing additives as described including 25 ng/ml of epidermal growth factor for TEC and RPMI164O + 10% FCS for CHO cell) supplemented with 1.5 mg/mI G4l8 (Gibco Laboratories, Grand Island, New York, USA). After drug selection, transfectants were maintained in culture medium containing 0.4 mg/mI G418. Fluorescence cytometry Subconfluent monolayers of TEC were cultured for 72 hours in modified Ki medium with or without IFN-y (100 U/mI). Cells were harvested by trypsinization, and resuspended at 5 x l0 to 1 x 10 cells/mi in PBS with 3% FBS/0.l% NaN3. Cells were analyzed for the surface expression of B7, 1Ak and I-E" using hamster anti-murine B7 mAb (16-1OA1), mouse antiIAk mAb (11-5.2) and mouse antiIEk mAb (l4.4.4S) followed by FITCconjugated anti-hamster or mouse IgG/goat IgG F(ab')2 antibodies (Cappel, West Chester, Pennsylvania, USA) before being analyzed by a FACscan Flow Cytometer (Becton Dickinson, Mountain View, California, USA). We analyzed 5,000 cells per sample. Rat IgG and mouse IgG were used as a negative control.
Induction of T cell anergy
A.E7 cells (7 x 105/well) were preincubated in 2.0 ml medium in 24-well plates with or without Ag, with I x 106 mitomycin C treated (100 g/ml x 1 hr at 37°C) TEC, mitomycin C-treated TEC-B7, mitomycin C treated IFN-y stimulated TEC or mitomycin C treated IFN-y stimulated TEC-B7. A.E7 cells were also cultured in medium alone, antigen pulsed irradiated (1500 R) syngeneic splenocytes or on anti-CD3 mAb-coated wells as controls. After 24 hours of culture, T cells recovered on Ficoll-Hypaque (Cedarlane Laboratory Ltd., Hornby, Ontario, Canada) density gradients and were rested for 48 to 72 hours prior to culture for three days in 96-well microtiter plates (2 to 3 X i0 cells/well) with 5 x l0 irradiated syngeneic splenocytes and Ag or with IL-2 alone. Proliferation and IL-2 response were assayed as described below.
Thi cell clone proliferation assay All cultures were performed in RPM! 1640 supplemented with 10% fetal bovine serum (FBS) (HyClone, Logan, Utah, USA), 50 tM 2-ME, 10 mrvi HEPES, 1 mivi Na pyruvate, 0.1 m non-essential amino acids, and antibiotics. Two to 3 x iO A.E7 cells were also cultured with 5 x io Ag pulsed mitomycin C treated TEC-B7 or mitomycin C treated IFN-y stimulated TEC-B7. As an Ag specific positive control, 5 x i0 irradiated splenic APC were cultured with varying doses of Ag. After three days of culture, wells were pulsed with 1 sCi of tritiated thymidine (3H-TdR, 6.7 mCi/mM; New England Nuclear, Boston, Massachusetts, USA) and harvested six hours later using a PHD cell harvester (Cambridge Technology Inc., Cambridge, Massachusetts). Thymidine incorporation was quantitated by liquid scintillation counting. Determinations were performed in triplicate. Background proliferation (without Ag) was < 1,000 cpm. Blocking experiments using anti-CD28 (37.51) and anti-B7 (16. 1OAI) mAb was included in each experiment. Hamster IgG served as controls.
T cell hybridoma response and IL-2 assay The response of A2A2 T cell hybridoma cells was evaluated by measuring IL-2 production for 24 hour stimulation with various doses of HEL. We assayed IL-2 by determining the ability of culture supernatants to support the growth of 2 x iO HT-2 cells. After 24 hours co-culture, each well was pulsed with 1 pCi of 3H TdR, and harvested these cultures six hours later and quantitated thymidine incorporation as described above.
As a positive control, we cultured HT-2 cells with serial dilutions of murine recombinant IL-2.
Results Anti-mouse CD28 and B7 mAbs block Ag presentation by splenic AFC In previous experiments, we first noted that cloned A.E7 ThI cells proliferate when cultured with irradiated syngeneic splenic APC and Ag, but do not respond to Ag pulsed IFN-y treated (Ia) TEC (data not shown). Since B7 has been shown to provide a costimulatory signal to resting T cells by binding to cell surface CD28/CTLA4 proteins, we examined the potential involvement of the CD28-B7 pathway in A.E7 Thi cell activation. As compared with A.E7 Thi cells and irradiated syngeneic splenic APC and Ag alone, the proliferation of A.E7 Thl cells Fig. 1 . Anti-mouse CD28 and B7 mAb block Ag presentation by splenic APCs. A. E7 cell proliferation was assayed by measuring incorporation of tritiated thymidine for last 6 hr of 3 days culture in triplicate, and is expressed as X SEM of three experiments.
A final concentration of 10 pg/mI of each mAb was added at the onset of culture. Inhibition by anti-CD28 (37.51) and anti-B7 (16-10A1) mAbs ranged from 97 to 99% and 56 to 93%, respectively. In these assays 2.5 x io A.E7 cells was used and a fixed number of irradiated (1500 R) splenic APC.
was blocked by the addition of either anti-B7 or anti-CD28 mAb to cultures (Fig. 1 ). These data suggested that A.E7 cloned Thi cells receive crucial costimulatory signal(s) via the CD28-B7 interaction. (Table 1) . Thus, A.E7 cells pre-cultured with Ag pulsed IFN-y stimulated-TEC or stimulated with anti-CD3 mAb were rendered anergic.
TEC-B7 cell lines express the B? ligand and can be stimulated with IFN-y to Induce I-A" and I-E" determinants Using flow cytometric analysis we detected both I-A" and I-E" expression on TEC following stimulation with IFN-y (Fig.2) . However, TEC with and without stimulation with IFN-ydid not express B7 on the cell surface (Fig. 2) . To further define the role of CD28/CTLA4 costimulation in T cell anergy induced by TEC, we transfected the mouse B7 encoding cDNA into TEC and CHO cells. CHO cells were studied in parallel to TEC, since they do not express any known costimulatory and 1 to 2%, respectively; Fig. 2 ). Surface expression of B7 molecules on TEC-B7 was also detectable by immunoperoxidase technique using rat anti-mouse B7 mAb. After transfection with B7 cDNA, it was established that TEC-B7 retained the capacity to be induced by IFN-y and express both lAk and I-E" determinants (Fig. 2) . B7 ligand expression on TEC does not provide a sufficient signal to induce A.E7 Thi cell proliferation, but does prevent anergy Previously, we reported that in response to Ag pulsed Ia TEC, T cell hybridomas produce IL-2, while A.E7 Thi cells do not proliferate and are in fact rendered anergic [34] . Therefore, we examined the capacity of Ia TEC-B7 to present Ag to the A2A2 T cell hybndoma and A.E7 Thi cells. Ag pulsed Ia TEC-B7 cells induced Ag-dependent IL-2 production by the A2A2 T cell hybridoma as detected by the HT-2 indicator line, but failed to stimulate A.E7 Thi cells to proliferate (Fig. 3 A, B  respectively) . A.E 7 cells were not rendered anergic by Ag pulsed Ia TEC-B7, since they were cabale of proliferating in a secondary culture to irradiated splenic APC pulsed with Ag (Table 2) . Thus, A.E7 cells cultured with Ia TEC-B7 with Ag behave as if they had never encountered Ag (immunological ignorance), that is, they did not proliferate nor were they rendered anergic.
A.E7 Thi cells required anti-CD3 mAb stimulation for
TEC-B7 or CHO-B7 cells to confer proliferation To determine whether cells transfected with B7 could provide a costimulatory signal, we co-cultured A.E7 Thl cells with either TEC-B7 with or without IFN-y stimulation or CHO-B7 cells. These B7 transfected TEC and CHO cells were compared with untransfected cells similarly prepared. To prevent the stimulator cells from dividing, the TEC and TEC-B7 were incubated with mitomycin C and the CHO and CHO-B7 cells fixed with paraformaldehyde. These cells were cocultured in plates coated with varying concentration of anti-CD3 mAb.
Anti-CD3 mAb alone at a dose of 0.1 to 10 g/ml did not stimulate A.E7 Thl cells to proliferate; however, the addition of 10 p.g/ml of anti-CD3 mAb to cultures also containing TEC-B7 or CHO-B7 stimulated A.E7 Thl cells to proliferate. By comparison, CHO cells and TEC did not stimulate A.E7 Thl cells to proliferate in the presence or absence of anti-CD3 mAb (Fig. 4) . The proliferative response of A.E7 Thi cell to TEC-B7 stimulated with anti-CD3 mAb was not altered by incubating TEC-B7 with IFN-y (data not shown). Furthermore, the proliferation of A.E7 Thl cells stimulated with anti-CD3 mAb and TEC-B7 requires the B7/CD28 ligand interaction, since both anti-B7 and anti-CD28 mAbs inhibited the A.E7 cell proliferation (Table 3 ).
Given the paucity of cells expressing the B7 ligand, it was concluded that only a few B7 transfected cells were required to provide a sufficient costimulatory signal for A.E7 Thl cells pre-stimulated via its TCR to proliferate.
Discussion
In theory, the attributes of stimulated TEC suggest that they might support APC-like activities [39] [40] [41] [42] [43] [44] [45] [46] [47] . Following cytokine stimulation, TEC can secrete a variety of molecules, including tumor necrosis factor-a, IL-6, IL-8, transforming growth factor (TGF)-f3, GM-CSF, MCP-1 and PDGF-p, and express cell surface molecules such as MHC-class land class II, ICAM-l or VCAM-l. Indeed, IFN-stimulated TEC expressing Ia can process and effectively present Ag to T cell hybridomas which are Ag specific and MHC restricted. T cell hybridomas can be readily activated through stimulation of the TCR alone to secrete IL-2. In fact, T cell hybridomas exposed to Ia bound Ag on a planar lipid membrane can be stimulated to release IL-2 [48] . However, T cell clones require a costimulatory signal (second signal) as well as a first signal delivered to the TCR either via (i) engagement with a specific Ag within the groove of the Ia molecule, or (ii) crosslinking mAb [2, [49] [50] [51] [52] . Although IFN-y treated, Ag pulsed TEC stimulate T cell hybridomas, our previous experiments revealed that Ag pulsed, IFN-y activated TEC not only fail to activate Thi clones, but they induced Ag specific unresponsiveness, that is, anergy, in these cloned Thl cells [34] . These results suggest that TEC fail to provide effective costimulatory signals that are required to support the activation of Thi cells.
Recently, a uniquely powerful costimulatory pathway has been defined involving the protein to protein interaction of CD28/CTLA4 on T cells with B7 upon APCs. This pathway utilizes a Ca2 protein kinase C independent signaling pathway that is completely distinct from the signaling pathway initiated by TCR stimulation [4, 5, 8, 9] . Dendritic cells constitutively express the B? molecule. B7 is also expressed on activated, but not resting B cells or MØ [11] [12] [13] 22] . While IFN-y stimulated MØ are induced to express B7, TEC do not express the B7 ligand following IFN-y treatment (Fig. 2) . TEC-B7, but not CHO-B7 transfectants, secrete and express membrane bound cytokines. Since TEC-B7 and CHO-B7 cells co-cultured with A.E7 Thl cells stimulated with anti-CD3 mAb proliferate, we have established that B7 alone can confer a sufficient second signal to A.E7 Thl cells. While TEC-B7 can process and proteins to cocluster in order to support T cell activation.
Clearly, A.E7 Thl cells receive a powerful costimulatory signal from the B7 ligand expressed on APCs and B7 transfectants. B7 can interact with two different molecules expressed on T cells: CD28 and CTLA-4 [18, 23] . Therefore, it was important to establish whether cells expressing B7 delivered a T cell activating signal via the CD28 or CTLA4 ligand. We determined that Ag specific mouse Th 1 cells received a potent costimulatory signal via its CD28 since blocking access of B7 to CD28 proteins with anti-murine CD28 mAb prevented T cell proliferation. Depending upon the experimental conditions anti-CD28 mAb can either activate or block CD4+ T cell activation. Costimulation requires exposure to bivalent mAb, however, in some situations either monovalent or bivalent anti-human CD28 mAb (clone 9.3 and L293) can block the costimulatory signal enabling Ag specific human T cell activation, such as in a mixed lymphocyte culture (MLC) or as induced by B7 transfectants (Fig.!, Table 3 ). The same phenomena were reported in systems using mouse splenic T cell and cloned Thl cell proliferation assays [2, 3] . Therefore, it is possible that the extent of cross linking of CD28 molecules may determine whether the stimulatory or inhibitory effects are caused by treatment with anti-CD28 mAb [6, 16] . When we exposed A.E7 Thi cells to irradiated splenic APC pulsed with Ag and added anti-CD28 mAb the Thl cells were rendered anergic (data not shown). These results are similar to the "anergizing" effects produced by the CTLA-41g fusion protein, which binds to B7 ligand on APCs [24] . In any event, our results highlight the important costimulating role in the CD28-B7 interaction upon the Ag specific response of mouse Thl clones.
In vitro, both the lack of a second signal and the intensity of the first signal, as described below, are important factors for determining whether T cell activation or anergy ensue, since T cells interacted with chemically modified Ag pulsed [49, 50] APC or either Con A or immobilized anti-CD3 mAb in the absence of APCs [53, 54] were rendered anergic. Following culture of T cells with functioning APC and certain nonstimulatory peptide analogues of a specific Ag, anergy is also induced. Use of non-stimulating mutant peptides to confer a modified first signal (a partial first signal), even in the presence of a powerful costimulatory stimulant causes T cell anergy rather than clonal expansion [55] . The exact mechanism by which T cell anergy is induced by Ag pulsed "non-professional" APCs such as TEC or thymic cortical epithelial cells is unknown [25] . For example, in our previous studies we failed to stimulate Thi clones by Ag pulsed, Ia TEC cocultured with either allogeneic peritoneal exudate cells or splenocytes [34] . Taken together, these results suggest one of several posibilities: (i) Ag pulsed, Ia TEC can only transmit a partial first signal to b % Inhibition of A.E7 cell proliferation by each antibody (10 tg/ml) was calculated as follows; 3H-TdR uptake with mAb (cpm) = uptake of control (cpm)/uptake of control (cpm) x 100 (%).
T cells that result in anergy; (ii) Ag pulsed, Ia TEC can provide the full first signal, but there is insufficient B7 expression to provide costimulation; (iii) both the first and second signals induced by Ag pulsed, Ia TEC are suboptimal for induction of T cell activation. To examine these points, B7 was transfected into SV4O transformed proximal TEC (CS3. 1) and CHO cells. It becomes clear that a small population of B7 transfectants among Ag pulsed, Ia TEC prevent Thl cells from being rendered anergic since fewer than 10% of the TEC-B7 population actually express detectable B7 molecules. Expression of B7 by "non-professional" APCs (TEC5) abolishes the capacity of such cells to induce anergy. Our results are in keeping with demonstration that in B7 transfected tumor cells are highly immunogenic [56, 57] . These results suggest that the first signal provided by Ag pulsed, Ia TEC is stronger than the signal induced by the non-stimulatory mutant peptide analogues that cause anergy, since APCs pulsed with these peptides render Thi clones anergic even if accompanied by an adequate second signal(s). In vivo expression of MHC-class II on TEC may serve to prevent or limit CD4-T cell-mediated immune injury during autoimmune attack. Therefore, the role of Ia in autoimmune tissue injury is complex and the outcome (T cell anergy, ignorance or proliferation) is dependent on the presence or absence of costimulation by surface molecules on TEC as well as the intensity of signal delivered to the TCR complex.
In conclusion, these studies indicate: (1) a far weaker antigenic signal can induce T cell anergy as compared to the intensity of the signal required to cause T cell proliferation. In this regard, our data are similar to the results with mutant Ag peptide pulsed APCs insofar as these cells do not promote T cell proliferation, but render T cells anergic [55] .
(ii) B7 expression provides a costimulatory signal, even a numerically small subset of B7 expressing cells can break anergy [7, 56, 57] . Thus, both a strong antigenic signal plus a costimulatory signal are required to induce Thi cell proliferation. Taken together, parenchymal epithelial cells may be ideally suited to induce anergy and protect from autoimmune tissue damage, since they lack expression of the B7 ligand and provide only weak antigenic stimulation. It is likely that Ia expression provides a vehicle to inhibit, not stimulate, autoimmunity.
